CoQ10 and Stroke Recovery: What the Science Actually ShowsCoQ10 and Stroke Recovery: What the Science Actually Shows
Recovery After Stroke
Bill Gasiamis breaks down what peer-reviewed research actually says about CoQ10 and brain health after stroke, highlighting both promise and limitations. The focus stays on evidence-based advice so survivors and carers can have better-informed discussions with their medical teams.
11:34•8 May 2026
CoQ10 and Stroke Recovery: Separating Hype from Honest Science
Episode Overview
- CoQ10 is central to cellular energy production and declines with age, which may affect brain function after stroke.
- Animal studies consistently show cognitive benefits from CoQ10, but human trials report mixed and condition-specific results.
- It remains uncertain how much CoQ10 crosses the blood–brain barrier, though it appears to support blood flow, inflammation and mitochondrial function.
- CoQ10 is generally safe but can interact with blood thinners and blood pressure medication, so medical advice is essential before starting.
- Choosing the ubiquinol form at appropriate doses and giving it several weeks to months is recommended if a doctor agrees it is suitable.
“"To make decisions grounded in science, not hope alone. That's the position you want to be in."”
In this eye-opening episode, you'll learn about a supplement many stroke survivors hear about but rarely get straight answers on: CoQ10. Aimed at stroke survivors and their carers, the show breaks down what the science actually says in clear, no-nonsense language. Host Bill Gasiamis, who has survived three strokes himself, sets the tone by explaining why energy matters so much to the healing brain.
He notes that the brain is just 2% of body weight but uses around 20% of the body's energy, making anything that affects cellular energy a big deal for recovery. From there, he walks through what CoQ10 is, how it supports ATP production in mitochondria, and why levels drop with age. Bill leans heavily on peer-reviewed research, not marketing hype.
He talks through a review of animal and human trials, highlighting that animal studies look promising across conditions like Alzheimer's, Parkinson's and epilepsy, but human results are mixed. Some trials show improvements in things like fatigue and frontal lobe function, while others show no clear benefit, even at high doses. He also raises a key unresolved issue: whether CoQ10 crosses the blood–brain barrier in useful amounts.
Rather than oversell it, he frames CoQ10 as a supplement with a logical biological basis and "a growing, but still limited and mixed, human evidence base"—very different from a proven treatment. Practical advice runs through the episode. Bill stresses talking to a doctor first, especially for anyone on blood thinners or blood pressure medication, choosing the more absorbable ubiquinol form, using realistic doses and timeframes, and, for some, considering participation in registered clinical trials.
Underlying it all is a push for informed choice. As Bill puts it, the goal is "to make decisions grounded in science, not hope alone." For anyone tired of wild supplement claims and looking for calm, evidence-based guidance, this is likely to hit the spot. How might your next conversation with your medical team change after hearing this?
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.